Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
TEVA
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion
The proposed settlement is the latest move by a company seeking to resolve the costly litigation. Under the terms, the...
Teva Found Liable for Fueling Opioid Addiction in New York
A jury in New York state found drugmaker Teva Pharmaceuticals Industries Ltd. liable for creating a public nuisance in the...
